NEURONES: Organic growth up 5.1% in 3rd quarter 2025

PRESS INFORMATIONHeading: 3 rdquarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3 rdquarter 2025(not audited, in millions of euros)20242025growthof which organic 3 rdquarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of...
Comunicato Precedente

next
Comunicato Successivo

next

PRESS INFORMATION
Heading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading)

Organic growth up 5.1% in 3rd quarter 2025

(not audited, in millions of euros) 2024 2025 growth of which organic
3rd quarter revenues 196.7 207.9 + 5.7% + 5.1%
Total as at the end-September 599.1 632.2 + 5.5% + 4.7%

Achievements

In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year.

Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Service Now) assignments and Business Process Management.

Turnover remained at a low level.

At 9.6% of revenues, the operating margin for the third quarter was up compared to the first half of the year. For the first nine months, it stood at 8.4%*.

Outlook

Given the improvement seen in the 3rd quarter, the group is now targeting annual revenues in excess of €850 million and operating profit of at least 8% for the full year.

* unaudited and after inclusion of 0.9% expenses related to bonus shares.

About NEURONES
With 7,300 experts, and ranking among the French leaders in consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

Euronext Paris (compartment A - NRO) – Euronext Tech Leaders – DSS – PEA-PME eligible
www.neurones.net

Press Relations:
O'Connection
Julia Philippe-Brutin
Tel.: +33 (0)6 03 63 06 03

[email protected]


NEURONES
Matthieu Vautier
Tel.: +33 (0)1 41 37 41 37
[email protected]
Investor Relations:
NEURONES
Paul-César Bonnel
Tel.: +33 (0)1 41 37 41 37
[email protected]

Attachment

  • neurones-third-quarter-2025-revenues

Per maggiori informazioni
Sito Web
neurones.fr

Ufficio Stampa

 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti

Allegati
Slide ShowSlide Show
Non disponibili
;